Table of Content

1 Prostate Cancer Drugs Market Overview
1.1 Product Overview and Scope of Prostate Cancer Drugs
1.2 Prostate Cancer Drugs Segment by Type
1.2.1 Global Prostate Cancer Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Hormonal Therapy
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.2.5 Targeted Therapy
1.3 Prostate Cancer Drugs Segment by Application
1.3.1 Global Prostate Cancer Drugs Market Value by Application: (2024-2034)
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Global Prostate Cancer Drugs Market Size Estimates and Forecasts
1.4.1 Global Prostate Cancer Drugs Revenue 2018-2034
1.4.2 Global Prostate Cancer Drugs Sales 2018-2034
1.4.3 Global Prostate Cancer Drugs Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Prostate Cancer Drugs Market Competition by Manufacturers
2.1 Global Prostate Cancer Drugs Sales Market Share by Manufacturers (2018-2024)
2.2 Global Prostate Cancer Drugs Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Prostate Cancer Drugs Average Price by Manufacturers (2018-2024)
2.4 Global Prostate Cancer Drugs Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Prostate Cancer Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prostate Cancer Drugs, Product Type & Application
2.7 Prostate Cancer Drugs Market Competitive Situation and Trends
2.7.1 Prostate Cancer Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prostate Cancer Drugs Players Market Share by Revenue
2.7.3 Global Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prostate Cancer Drugs Retrospective Market Scenario by Region
3.1 Global Prostate Cancer Drugs Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Prostate Cancer Drugs Global Prostate Cancer Drugs Sales by Region: 2018-2034
3.2.1 Global Prostate Cancer Drugs Sales by Region: 2018-2024
3.2.2 Global Prostate Cancer Drugs Sales by Region: 2024-2034
3.3 Global Prostate Cancer Drugs Global Prostate Cancer Drugs Revenue by Region: 2018-2034
3.3.1 Global Prostate Cancer Drugs Revenue by Region: 2018-2024
3.3.2 Global Prostate Cancer Drugs Revenue by Region: 2024-2034
3.4 North America Prostate Cancer Drugs Market Facts & Figures by Country
3.4.1 North America Prostate Cancer Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Prostate Cancer Drugs Sales by Country (2018-2034)
3.4.3 North America Prostate Cancer Drugs Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prostate Cancer Drugs Market Facts & Figures by Country
3.5.1 Europe Prostate Cancer Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Prostate Cancer Drugs Sales by Country (2018-2034)
3.5.3 Europe Prostate Cancer Drugs Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prostate Cancer Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Prostate Cancer Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Prostate Cancer Drugs Sales by Country (2018-2034)
3.6.3 Asia Pacific Prostate Cancer Drugs Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Prostate Cancer Drugs Market Facts & Figures by Country
3.7.1 Latin America Prostate Cancer Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Prostate Cancer Drugs Sales by Country (2018-2034)
3.7.3 Latin America Prostate Cancer Drugs Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prostate Cancer Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Prostate Cancer Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Prostate Cancer Drugs Sales by Country (2018-2034)
3.8.3 Middle East and Africa Prostate Cancer Drugs Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prostate Cancer Drugs Sales by Type (2018-2034)
4.1.1 Global Prostate Cancer Drugs Sales by Type (2018-2024)
4.1.2 Global Prostate Cancer Drugs Sales by Type (2024-2034)
4.1.3 Global Prostate Cancer Drugs Sales Market Share by Type (2018-2034)
4.2 Global Prostate Cancer Drugs Revenue by Type (2018-2034)
4.2.1 Global Prostate Cancer Drugs Revenue by Type (2018-2024)
4.2.2 Global Prostate Cancer Drugs Revenue by Type (2024-2034)
4.2.3 Global Prostate Cancer Drugs Revenue Market Share by Type (2018-2034)
4.3 Global Prostate Cancer Drugs Price by Type (2018-2034)
5 Segment by Application
5.1 Global Prostate Cancer Drugs Sales by Application (2018-2034)
5.1.1 Global Prostate Cancer Drugs Sales by Application (2018-2024)
5.1.2 Global Prostate Cancer Drugs Sales by Application (2024-2034)
5.1.3 Global Prostate Cancer Drugs Sales Market Share by Application (2018-2034)
5.2 Global Prostate Cancer Drugs Revenue by Application (2018-2034)
5.2.1 Global Prostate Cancer Drugs Revenue by Application (2018-2024)
5.2.2 Global Prostate Cancer Drugs Revenue by Application (2024-2034)
5.2.3 Global Prostate Cancer Drugs Revenue Market Share by Application (2018-2034)
5.3 Global Prostate Cancer Drugs Price by Application (2018-2034)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.1.4 AbbVie Prostate Cancer Drugs Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Astellas Pharma
6.2.1 Astellas Pharma Corporation Information
6.2.2 Astellas Pharma Description and Business Overview
6.2.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Astellas Pharma Prostate Cancer Drugs Product Portfolio
6.2.5 Astellas Pharma Recent Developments/Updates
6.3 Astra Zeneca
6.3.1 Astra Zeneca Corporation Information
6.3.2 Astra Zeneca Description and Business Overview
6.3.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Astra Zeneca Prostate Cancer Drugs Product Portfolio
6.3.5 Astra Zeneca Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Johnson & Johnson Prostate Cancer Drugs Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Sanofi Prostate Cancer Drugs Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.6.4 GlaxoSmithKline Prostate Cancer Drugs Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Merck Group
6.6.1 Merck Group Corporation Information
6.6.2 Merck Group Description and Business Overview
6.6.3 Merck Group Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Merck Group Prostate Cancer Drugs Product Portfolio
6.7.5 Merck Group Recent Developments/Updates
6.8 Novartis
6.8.1 Novartis Corporation Information
6.8.2 Novartis Description and Business Overview
6.8.3 Novartis Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Novartis Prostate Cancer Drugs Product Portfolio
6.8.5 Novartis Recent Developments/Updates
6.9 Amgen
6.9.1 Amgen Corporation Information
6.9.2 Amgen Description and Business Overview
6.9.3 Amgen Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Amgen Prostate Cancer Drugs Product Portfolio
6.9.5 Amgen Recent Developments/Updates
6.10 Bayer HealthCare
6.10.1 Bayer HealthCare Corporation Information
6.10.2 Bayer HealthCare Description and Business Overview
6.10.3 Bayer HealthCare Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Bayer HealthCare Prostate Cancer Drugs Product Portfolio
6.10.5 Bayer HealthCare Recent Developments/Updates
6.11 Ferring Pharmaceutical
6.11.1 Ferring Pharmaceutical Corporation Information
6.11.2 Ferring Pharmaceutical Prostate Cancer Drugs Description and Business Overview
6.11.3 Ferring Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Ferring Pharmaceutical Prostate Cancer Drugs Product Portfolio
6.11.5 Ferring Pharmaceutical Recent Developments/Updates
6.12 Janssen Pharmaceuticals
6.12.1 Janssen Pharmaceuticals Corporation Information
6.12.2 Janssen Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.12.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Janssen Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.12.5 Janssen Pharmaceuticals Recent Developments/Updates
6.13 Endo Pharmaceuticals
6.13.1 Endo Pharmaceuticals Corporation Information
6.13.2 Endo Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.13.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Endo Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.13.5 Endo Pharmaceuticals Recent Developments/Updates
6.14 BMS
6.14.1 BMS Corporation Information
6.14.2 BMS Prostate Cancer Drugs Description and Business Overview
6.14.3 BMS Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.14.4 BMS Prostate Cancer Drugs Product Portfolio
6.14.5 BMS Recent Developments/Updates
6.15 Takeda Pharmaceuticals
6.15.1 Takeda Pharmaceuticals Corporation Information
6.15.2 Takeda Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Takeda Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.15.5 Takeda Pharmaceuticals Recent Developments/Updates
6.16 Northwest Biotherapeutics
6.16.1 Northwest Biotherapeutics Corporation Information
6.16.2 Northwest Biotherapeutics Prostate Cancer Drugs Description and Business Overview
6.16.3 Northwest Biotherapeutics Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Northwest Biotherapeutics Prostate Cancer Drugs Product Portfolio
6.16.5 Northwest Biotherapeutics Recent Developments/Updates
6.17 Teva Pharmaceutical
6.17.1 Teva Pharmaceutical Corporation Information
6.17.2 Teva Pharmaceutical Prostate Cancer Drugs Description and Business Overview
6.17.3 Teva Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Teva Pharmaceutical Prostate Cancer Drugs Product Portfolio
6.17.5 Teva Pharmaceutical Recent Developments/Updates
6.18 Boehringer Ingelheim
6.18.1 Boehringer Ingelheim Corporation Information
6.18.2 Boehringer Ingelheim Prostate Cancer Drugs Description and Business Overview
6.18.3 Boehringer Ingelheim Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Boehringer Ingelheim Prostate Cancer Drugs Product Portfolio
6.18.5 Boehringer Ingelheim Recent Developments/Updates
6.19 Foresee Pharmaceuticals
6.19.1 Foresee Pharmaceuticals Corporation Information
6.19.2 Foresee Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Foresee Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.19.5 Foresee Pharmaceuticals Recent Developments/Updates
6.20 Tokai Pharmaceuticals
6.20.1 Tokai Pharmaceuticals Corporation Information
6.20.2 Tokai Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.20.3 Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Tokai Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.20.5 Tokai Pharmaceuticals Recent Developments/Updates
6.21 Spectrum Pharmaceuticals
6.21.1 Spectrum Pharmaceuticals Corporation Information
6.21.2 Spectrum Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.21.4 Spectrum Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.21.5 Spectrum Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prostate Cancer Drugs Industry Chain Analysis
7.2 Prostate Cancer Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prostate Cancer Drugs Production Mode & Process
7.4 Prostate Cancer Drugs Sales and Marketing
7.4.1 Prostate Cancer Drugs Sales Channels
7.4.2 Prostate Cancer Drugs Distributors
7.5 Prostate Cancer Drugs Customers
8 Prostate Cancer Drugs Market Dynamics
8.1 Prostate Cancer Drugs Industry Trends
8.2 Prostate Cancer Drugs Market Drivers
8.3 Prostate Cancer Drugs Market Challenges
8.4 Prostate Cancer Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Prostate Cancer Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Prostate Cancer Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Prostate Cancer Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Prostate Cancer Drugs Sales (K MT) of Key Manufacturers (2018-2024)
Table 5. Global Prostate Cancer Drugs Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Prostate Cancer Drugs Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Prostate Cancer Drugs Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Prostate Cancer Drugs Average Price (USD/MT) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Prostate Cancer Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Prostate Cancer Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Prostate Cancer Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Prostate Cancer Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Prostate Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Prostate Cancer Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Prostate Cancer Drugs Sales by Region (2018-2024) & (K MT)
Table 18. Global Prostate Cancer Drugs Sales Market Share by Region (2018-2024)
Table 19. Global Prostate Cancer Drugs Sales by Region (2024-2034) & (K MT)
Table 20. Global Prostate Cancer Drugs Sales Market Share by Region (2024-2034)
Table 21. Global Prostate Cancer Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Prostate Cancer Drugs Revenue Market Share by Region (2018-2024)
Table 23. Global Prostate Cancer Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Prostate Cancer Drugs Revenue Market Share by Region (2024-2034)
Table 25. North America Prostate Cancer Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Prostate Cancer Drugs Sales by Country (2018-2024) & (K MT)
Table 27. North America Prostate Cancer Drugs Sales by Country (2024-2034) & (K MT)
Table 28. North America Prostate Cancer Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Prostate Cancer Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Prostate Cancer Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Prostate Cancer Drugs Sales by Country (2018-2024) & (K MT)
Table 32. Europe Prostate Cancer Drugs Sales by Country (2024-2034) & (K MT)
Table 33. Europe Prostate Cancer Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Prostate Cancer Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Prostate Cancer Drugs Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Prostate Cancer Drugs Sales by Region (2018-2024) & (K MT)
Table 37. Asia Pacific Prostate Cancer Drugs Sales by Region (2024-2034) & (K MT)
Table 38. Asia Pacific Prostate Cancer Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Prostate Cancer Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Prostate Cancer Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Prostate Cancer Drugs Sales by Country (2018-2024) & (K MT)
Table 42. Latin America Prostate Cancer Drugs Sales by Country (2024-2034) & (K MT)
Table 43. Latin America Prostate Cancer Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Prostate Cancer Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Prostate Cancer Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Prostate Cancer Drugs Sales by Country (2018-2024) & (K MT)
Table 47. Middle East & Africa Prostate Cancer Drugs Sales by Country (2024-2034) & (K MT)
Table 48. Middle East & Africa Prostate Cancer Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Prostate Cancer Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Prostate Cancer Drugs Sales (K MT) by Type (2018-2024)
Table 51. Global Prostate Cancer Drugs Sales (K MT) by Type (2024-2034)
Table 52. Global Prostate Cancer Drugs Sales Market Share by Type (2018-2024)
Table 53. Global Prostate Cancer Drugs Sales Market Share by Type (2024-2034)
Table 54. Global Prostate Cancer Drugs Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Prostate Cancer Drugs Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Prostate Cancer Drugs Revenue Market Share by Type (2018-2024)
Table 57. Global Prostate Cancer Drugs Revenue Market Share by Type (2024-2034)
Table 58. Global Prostate Cancer Drugs Price (USD/MT) by Type (2018-2024)
Table 59. Global Prostate Cancer Drugs Price (USD/MT) by Type (2024-2034)
Table 60. Global Prostate Cancer Drugs Sales (K MT) by Application (2018-2024)
Table 61. Global Prostate Cancer Drugs Sales (K MT) by Application (2024-2034)
Table 62. Global Prostate Cancer Drugs Sales Market Share by Application (2018-2024)
Table 63. Global Prostate Cancer Drugs Sales Market Share by Application (2024-2034)
Table 64. Global Prostate Cancer Drugs Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Prostate Cancer Drugs Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Prostate Cancer Drugs Revenue Market Share by Application (2018-2024)
Table 67. Global Prostate Cancer Drugs Revenue Market Share by Application (2024-2034)
Table 68. Global Prostate Cancer Drugs Price (USD/MT) by Application (2018-2024)
Table 69. Global Prostate Cancer Drugs Price (USD/MT) by Application (2024-2034)
Table 70. AbbVie Corporation Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 73. AbbVie Prostate Cancer Drugs Product
Table 74. AbbVie Recent Developments/Updates
Table 75. Astellas Pharma Corporation Information
Table 76. Astellas Pharma Description and Business Overview
Table 77. Astellas Pharma Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 78. Astellas Pharma Prostate Cancer Drugs Product
Table 79. Astellas Pharma Recent Developments/Updates
Table 80. Astra Zeneca Corporation Information
Table 81. Astra Zeneca Description and Business Overview
Table 82. Astra Zeneca Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 83. Astra Zeneca Prostate Cancer Drugs Product
Table 84. Astra Zeneca Recent Developments/Updates
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 88. Johnson & Johnson Prostate Cancer Drugs Product
Table 89. Johnson & Johnson Recent Developments/Updates
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 93. Sanofi Prostate Cancer Drugs Product
Table 94. Sanofi Recent Developments/Updates
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Business Overview
Table 97. GlaxoSmithKline Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 98. GlaxoSmithKline Prostate Cancer Drugs Product
Table 99. GlaxoSmithKline Recent Developments/Updates
Table 100. Merck Group Corporation Information
Table 101. Merck Group Description and Business Overview
Table 102. Merck Group Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 103. Merck Group Prostate Cancer Drugs Product
Table 104. Merck Group Recent Developments/Updates
Table 105. Novartis Corporation Information
Table 106. Novartis Description and Business Overview
Table 107. Novartis Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 108. Novartis Prostate Cancer Drugs Product
Table 109. Novartis Recent Developments/Updates
Table 110. Amgen Corporation Information
Table 111. Amgen Description and Business Overview
Table 112. Amgen Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 113. Amgen Prostate Cancer Drugs Product
Table 114. Amgen Recent Developments/Updates
Table 115. Bayer HealthCare Corporation Information
Table 116. Bayer HealthCare Description and Business Overview
Table 117. Bayer HealthCare Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 118. Bayer HealthCare Prostate Cancer Drugs Product
Table 119. Bayer HealthCare Recent Developments/Updates
Table 120. Ferring Pharmaceutical Corporation Information
Table 121. Ferring Pharmaceutical Description and Business Overview
Table 122. Ferring Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 123. Ferring Pharmaceutical Prostate Cancer Drugs Product
Table 124. Ferring Pharmaceutical Recent Developments/Updates
Table 125. Janssen Pharmaceuticals Corporation Information
Table 126. Janssen Pharmaceuticals Description and Business Overview
Table 127. Janssen Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 128. Janssen Pharmaceuticals Prostate Cancer Drugs Product
Table 129. Janssen Pharmaceuticals Recent Developments/Updates
Table 130. Endo Pharmaceuticals Corporation Information
Table 131. Endo Pharmaceuticals Description and Business Overview
Table 132. Endo Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 133. Endo Pharmaceuticals Prostate Cancer Drugs Product
Table 134. Endo Pharmaceuticals Recent Developments/Updates
Table 135. BMS Corporation Information
Table 136. BMS Description and Business Overview
Table 137. BMS Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 138. BMS Prostate Cancer Drugs Product
Table 139. BMS Recent Developments/Updates
Table 140. Takeda Pharmaceuticals Corporation Information
Table 141. Takeda Pharmaceuticals Description and Business Overview
Table 142. Takeda Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 143. Takeda Pharmaceuticals Prostate Cancer Drugs Product
Table 144. Takeda Pharmaceuticals Recent Developments/Updates
Table 145. Northwest Biotherapeutics Corporation Information
Table 146. Northwest Biotherapeutics Description and Business Overview
Table 147. Northwest Biotherapeutics Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 148. Northwest Biotherapeutics Prostate Cancer Drugs Product
Table 149. Northwest Biotherapeutics Recent Developments/Updates
Table 150. Teva Pharmaceutical Corporation Information
Table 151. Teva Pharmaceutical Description and Business Overview
Table 152. Teva Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 153. Teva Pharmaceutical Prostate Cancer Drugs Product
Table 154. Teva Pharmaceutical Recent Developments/Updates
Table 155. Boehringer Ingelheim Corporation Information
Table 156. Boehringer Ingelheim Description and Business Overview
Table 157. Boehringer Ingelheim Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 158. Boehringer Ingelheim Prostate Cancer Drugs Product
Table 159. Boehringer Ingelheim Recent Developments/Updates
Table 160. Foresee Pharmaceuticals Corporation Information
Table 161. Foresee Pharmaceuticals Description and Business Overview
Table 162. Foresee Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 163. Foresee Pharmaceuticals Prostate Cancer Drugs Product
Table 164. Foresee Pharmaceuticals Recent Developments/Updates
Table 165. Tokai Pharmaceuticals Corporation Information
Table 166. Tokai Pharmaceuticals Description and Business Overview
Table 167. Tokai Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 168. Tokai Pharmaceuticals Prostate Cancer Drugs Product
Table 169. Tokai Pharmaceuticals Recent Developments/Updates
Table 170. Spectrum Pharmaceuticals Corporation Information
Table 171. Spectrum Pharmaceuticals Description and Business Overview
Table 172. Spectrum Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 173. Spectrum Pharmaceuticals Prostate Cancer Drugs Product
Table 174. Spectrum Pharmaceuticals Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Prostate Cancer Drugs Distributors List
Table 178. Prostate Cancer Drugs Customers List
Table 179. Prostate Cancer Drugs Market Trends
Table 180. Prostate Cancer Drugs Market Drivers
Table 181. Prostate Cancer Drugs Market Challenges
Table 182. Prostate Cancer Drugs Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Prostate Cancer Drugs
Figure 2. Global Prostate Cancer Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Prostate Cancer Drugs Market Share by Type in 2022 & 2034
Figure 4. Hormonal Therapy Product Picture
Figure 5. Chemotherapy Product Picture
Figure 6. Immunotherapy Product Picture
Figure 7. Targeted Therapy Product Picture
Figure 8. Global Prostate Cancer Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Prostate Cancer Drugs Market Share by Application in 2022 & 2034
Figure 10. Clinics
Figure 11. Hospitals
Figure 12. Others
Figure 13. Global Prostate Cancer Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Prostate Cancer Drugs Market Size (2018-2034) & (US$ Million)
Figure 15. Global Prostate Cancer Drugs Sales (2018-2034) & (K MT)
Figure 16. Global Prostate Cancer Drugs Average Price (USD/MT) & (2018-2034)
Figure 17. Prostate Cancer Drugs Report Years Considered
Figure 18. Prostate Cancer Drugs Sales Share by Manufacturers in 2022
Figure 19. Global Prostate Cancer Drugs Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Prostate Cancer Drugs Players: Market Share by Revenue in 2022
Figure 21. Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Prostate Cancer Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 23. North America Prostate Cancer Drugs Sales Market Share by Country (2018-2034)
Figure 24. North America Prostate Cancer Drugs Revenue Market Share by Country (2018-2034)
Figure 25. U.S. Prostate Cancer Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Canada Prostate Cancer Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Europe Prostate Cancer Drugs Sales Market Share by Country (2018-2034)
Figure 28. Europe Prostate Cancer Drugs Revenue Market Share by Country (2018-2034)
Figure 29. Germany Prostate Cancer Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. France Prostate Cancer Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. U.K. Prostate Cancer Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Italy Prostate Cancer Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Russia Prostate Cancer Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Asia Pacific Prostate Cancer Drugs Sales Market Share by Region (2018-2034)
Figure 35. Asia Pacific Prostate Cancer Drugs Revenue Market Share by Region (2018-2034)
Figure 36. China Prostate Cancer Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Japan Prostate Cancer Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. South Korea Prostate Cancer Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. India Prostate Cancer Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Australia Prostate Cancer Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. China Taiwan Prostate Cancer Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Indonesia Prostate Cancer Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Thailand Prostate Cancer Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Malaysia Prostate Cancer Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Latin America Prostate Cancer Drugs Sales Market Share by Country (2018-2034)
Figure 46. Latin America Prostate Cancer Drugs Revenue Market Share by Country (2018-2034)
Figure 47. Mexico Prostate Cancer Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Brazil Prostate Cancer Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Argentina Prostate Cancer Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Middle East & Africa Prostate Cancer Drugs Sales Market Share by Country (2018-2034)
Figure 51. Middle East & Africa Prostate Cancer Drugs Revenue Market Share by Country (2018-2034)
Figure 52. Turkey Prostate Cancer Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Saudi Arabia Prostate Cancer Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. UAE Prostate Cancer Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Global Sales Market Share of Prostate Cancer Drugs by Type (2018-2034)
Figure 56. Global Revenue Market Share of Prostate Cancer Drugs by Type (2018-2034)
Figure 57. Global Prostate Cancer Drugs Price (USD/MT) by Type (2018-2034)
Figure 58. Global Sales Market Share of Prostate Cancer Drugs by Application (2018-2034)
Figure 59. Global Revenue Market Share of Prostate Cancer Drugs by Application (2018-2034)
Figure 60. Global Prostate Cancer Drugs Price (USD/MT) by Application (2018-2034)
Figure 61. Prostate Cancer Drugs Value Chain
Figure 62. Prostate Cancer Drugs Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed